Vaishali Pharma - Quaterly Results

21 Jan 2022 Evaluate
The Total revenue for the quarter ended December 2021 of  Rs. 222.82 millions remain, more or less, the same.A slender decline of -6.62% was recorded to Rs. 16.07  millions from Rs. 17.21 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 27.94 millions from 30.18 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 222.82 212.96 4.63 504.13 348.92 44.48 537.74 600.86 -10.50
Other Income 3.05 3.21 -4.98 12.37 12.36 0.08 18.09 21.73 -16.75
PBIDT 27.94 30.18 -7.42 72.11 52.28 37.93 44.41 29.98 48.13
Interest 5.48 5.86 -6.48 18.11 15.43 17.37 26.11 24.81 5.24
PBDT 22.46 24.32 -7.65 54.00 36.85 46.54 18.30 5.17 253.97
Depreciation 1.03 1.06 -2.83 3.07 3.14 -2.23 4.27 4.38 -2.51
PBT 21.43 23.26 -7.87 50.93 33.71 51.08 14.03 0.79 1675.95
TAX 5.36 6.05 -11.40 12.74 8.77 45.27 3.58 0.46 678.26
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.21 -0.10 110.00
PAT 16.07 17.21 -6.62 38.19 24.94 53.13 10.45 0.33 3066.67
Equity 105.46 105.46 0.00 105.46 105.46 0.00 105.46 105.46 0.00
PBIDTM(%) 12.54 14.17 -11.52 14.30 14.98 -4.54 8.26 4.99 65.52
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.